Otsuka Novel Products GmbH (ONPG) is dedicated to finding innovative solutions to fight the global pandemic of tuberculosis (TB).

Working in collaboration with other Otsuka Group companies and various stakeholders, ONPG focuses on providing access to innovative products for the treatment of TB and working to stop the spread of antimicrobial resistance.

ONPG is located in Munich, Germany, and is a part of Otsuka Pharmaceutical Co., Ltd., a subsidiary of Otsuka Holdings Co., Ltd., headquartered in Tokyo, Japan.

Otsuka Pharmaceutical is a global healthcare company with the corporate philosophy:
“Otsuka - people creating new products for better health worldwide.”

Otsuka researches, develops, manufactures, and markets innovative products, with a focus on pharmaceutical products to meet unmet medical needs and nutraceutical products for the maintenance of everyday health.

All Otsuka stories start by taking the road less travelled. Learn more about Otsuka Pharmaceutical at www.otsuka.co.jp/en/.

Information current as of 26-06-2017